首页> 外国专利> Prodrugs gem - disphophoniques of amethopterin (methotrexate) and derivatives deaza - n - 10 amethopterin, pharmaceutical compositions containing such prodrugs, 1995, and products #.

Prodrugs gem - disphophoniques of amethopterin (methotrexate) and derivatives deaza - n - 10 amethopterin, pharmaceutical compositions containing such prodrugs, 1995, and products #.

机译:前药宝石-氨蝶呤(甲氨蝶呤)和衍生物deaza的脱羧-n-10氨蝶呤,含有此类前药的药物组合物,1995年,产品编号。

摘要

The synthesis of gem-diphosphonic amethopterin(methotrexate) analogues, and their use as pharmaceutical compositions for various therapeutical applications, are described. In particular, an association of the pro-drug concept with the pharmacological vectorization of antineoplastic agents for bone carcinomata, using diphosphonic acids, is desired. The gem-diphosphonic amethopterin(methotrexate) and 10-N-deaza amethopterin compounds have the form of an amethopterin pro-drug of which the gem-diphosphonic grouping is connected to the pteroylglutamic grouping by a peptide linkage. These compounds are particularly useful in cancerological pharmaceutical compositions particularly intended for treating tumours or metastases, especially those to bone, and/or in rheumatological pharmaceutical compositions particularly intended for treating resistant psoriatic rheumatism, polymyositis, Reiter's disease and rheumatoid arthritis.
机译:描述了宝石-二膦酸氨基蝶呤(甲氨蝶呤)类似物的合成及其作为用于各种治疗应用的药物组合物的用途。特别地,期望使用二膦酸将前药概念与抗癌药的药理学载体化相关联。宝石-二膦酸氨基蝶呤(甲氨蝶呤)和10-N-脱氮氨基甲基蝶呤化合物具有氨基蝶呤前药的形式,该药物的宝石-二膦酸酯基通过肽键与蝶酰基谷氨酸基连接。这些化合物在特别用于治疗肿瘤或转移瘤,特别是对骨肿瘤的癌变药物组合物中和/或在特别用于治疗抵抗性银屑病风湿病,多发性肌炎,雷特氏病和类风湿性关节炎的风湿病药物组合物中特别有用。

著录项

  • 公开/公告号JPH06501240A

    专利类型

  • 公开/公告日1994-02-10

    原文格式PDF

  • 申请/专利权人

    申请/专利号JP19910508758

  • 发明设计人

    申请日1991-04-23

  • 分类号C07F9/6561;A61K31/505;A61K31/675;C07D475/06;

  • 国家 JP

  • 入库时间 2022-08-22 04:57:11

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号